HIV合并HCV抗病毒治疗新进展北京丙肝医院-培训课件.pptVIP

HIV合并HCV抗病毒治疗新进展北京丙肝医院-培训课件.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
* * 总结 HIV合并HBV和HCV非常普遍,HBV/HCV能够加重HIV的进展,并可能影响ART疗效,对这些患者应同时考虑保护肝脏功能和治疗HIV感染 性传播已经成为我国HIV传播的主要途径,是我国全面控制HIV/AIDS的关键,最新的数据显示,早期干预能使单阳伴侣的HIV传播风险降低96% HIV/HCV合并感染增加死亡率 HIV 加重 HCV 疾病: 导致持续的HCV病毒血症 ? 终末期肝病 (肝纤维化 肝硬化) ? 肝细胞癌 加速肝纤维化进程: ~20 vs 30 年 炎症加重(vs HCV alone) 肝外表现加重 HCV 加重HIV 进程: ? HIV抗病毒治疗药物的肝毒性 加速HIV疾病进程 * Sulkowski MS. J Hepatol. 2008;48:353-367. Gebo KA, et al. J Acquir Immune Defic Syndr. 2003;34:165-173. Weber R, et al. Arch Intern Med. 2006;166:1632-1641. 谢谢聆听! * Reference: Salmon-Ceron D et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42:799-805. In a French study of 822 HIV-infected patients, 29% were coinfected with HCV. Among the HIV/HCV coinfected group, the most frequent causes of death were end-stage liver disease (31%) and AIDS (29%). Reference Salmon-Ceron D, Lewden C, Morlat P, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42:799-805. Slide 3 – Disease progression in hepatitis C: person-to-person variability The course of HCV infection varies widely between individuals. Various factors influence the rate of progression. Female sex and young age at the time of infection are factors that decrease the risk of disease progression. In contrast, alcohol use and co-infection with HIV or hepatitis B virus increase the risk of disease progression.1 An acute symptomatic phase of liver inflammation may occur 15-50 days after infection, but 60-70% of cases are asymptomatic. Approximately 80% of patients with acute HCV develop chronic infection; however, some patients clear HCV spontaneously. Cirrhosis develops in up to 20% of patients with chronic hepatitis C over 20-30 years.2 Once cirrhosis is established, complications such as jaundice, ascites, variceal haemorrhage and encephalopathy can develop. These complications mark the transition from compensated to decompensa

文档评论(0)

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档